Alsup Trims Drug Co. Investors' Cancer Treatment Study Suit
A federal judge in San Francisco has trimmed claims from a proposed securities class action accusing biotechnology company Geron Corp. and its chief executive officer of failing to properly explain the...To view the full article, register now.
Already a subscriber? Click here to view full article